Medical · by Epocrates
epocrates Meta Ads & Creative Strategy
Ads refreshed July 27, 2026 · Meta Ad Library
0★ 0 ratings View on the App Store ↗
Every long-running ad epocrates runs on Facebook & Instagram — pulled from the public Meta Ad Library, x-rayed by the same system that runs ad accounts autonomously.
Active ads
75
Winning set
31
30+ days live
Longest live
267d
App rating
4.44★
7.1K ratings
Brand palette
The short version
Key facts
- As of July 27, 2026, epocrates runs 75 active ads in Meta's Ad Library across Facebook and Instagram; 31 of them have survived 30 or more days of continuous delivery.
- Its longest-running ad has been live for 267 days.
- The winning set splits 100% static.
- The most common message angle is discount offer, carried by 29% of the winning set.
- The winning ads speak mainly to Free-Tier Clinician Ready to Upgrade (29% of ads) and Tech-Forward Clinical Innovator (26%).
- All winning copy runs in English.
- In App Store reviews, the loudest praise goes to long term loyalty (2% of mentions) and the loudest complaint is pricing/paywall shift (33%).
- The App Store listing holds 0 stars across 0 ratings.
The winning set
Live Meta ads gallery
31 ads have survived 30+ days of continuous delivery, out of 75 currently active. Deduped by creative, that's 30 unique units below; the ×N badge counts the ads running each one. Tap to play, or open the Ad Library record. Sorted by longest live: the account's most proven creatives lead, podium first.
267d dco EN
Close-up shot of a laser tattoo removal procedure in progress.
209d dco EN
A close-up, high-contrast product shot of a medical vial and syringe.
199d dco EN
Your Clinical Intelligence Platform
199d dco EN
Your Clinical Intelligence Platform
199d dco EN
Your Clinical Intelligence Platform
199d dco EN
Your Clinical Intelligence Platform
199d dco EN
Your Clinical Intelligence Platform
199d dco EN
Your Clinical Intelligence Platform
164d dco EN
Save 50% Trusted clinical decision support
164d dco EN
Save 50% Trusted clinical decision support
164d dco EN
Save 50% on epocrates+
164d dco EN
Save 50% Trusted clinical decision support
162d dco EN
Save 50% on epocrates+
162d dco EN
Save 50% on epocrates+
136d dco EN
Save 50%
136d dco EN
Save 50% $149.95 / first year
135d dco EN
Save 50%
111d image ×2 ads EN
A close-up, high-contrast product shot of a medical vial and syringe.
109d image EN
Close-up shot of a laser tattoo removal procedure in progress.
106d dco EN
A collection of five different alcoholic beverages arranged on a bar surface.
106d dco EN
A close-up shot of a person preparing to inject medication into their abdomen.
105d image EN
A close-up shot of a person preparing to inject medication into their abdomen.
55d dco EN
Close-up shot of a medical professional administering an injection to an elderly patient's arm.
54d image EN
Close-up shot of a medical professional administering an injection to an elderly patient's arm.
The x-ray — every winner analyzed frame by frame
What the winning set is actually doing
Language distribution — where the winning set actually runs
Share of the winning set per copy language. Translation is a deliberate spend decision: a language earning survivors is a market the money already believes in.
English
100% · 31 ads
Format split — statics vs video in the winning set
What survives 30+ days by medium.
static 31 ads · 100%
Persona coverage — who the winning ads speak to
HyperScale agents read epocrates's buyer personas out of the winning set itself, then tagged every ad with the buyer it addresses.
Free-Tier Clinician Ready to Upgrade
29% · 9 ads
Tech-Forward Clinical Innovator
26% · 8 ads
Lifestyle-Risk Counseling Clinician
19% · 6 ads
Bedside Prescriber Needing Instant Dosing Info
10% · 3 ads
Vaccine and Prevention-Focused Clinician
10% · 3 ads
GLP-1 and Weight-Loss Drug Manager
6% · 2 ads
Every x-rayed creative is tagged individually (who it sells to, its angle) from its HyperScale x-ray: transcript, casting, story beats. Coverage counts the ads each creative carries.
Angle mix — what the money says works
Every winner tagged with the message angle it leads with, and the languages it runs in — longevity under spend is the only public vote that counts.
discount offer
29% · 9 ads
platform positioning
26% · 8 ads
lifestyle risk visual
13% · 4 ads
dosing visual proof
10% · 3 ads
clinical topic demo
6% · 2 ads
self-injection demo
6% · 2 ads
vaccine administration demo
6% · 2 ads
reassurance imagery
3% · 1 ads
The full winning set, read from the creatives themselves — 31 analyzed winners, hook by hook.
| Days live | Ads | Lang | Angle | Persona | On-screen headline | Format |
|---|---|---|---|---|---|---|
| 267d | ×3 | en | clinical topic demo | Lifestyle-Risk Counseling Clinician | DCO | |
| 209d | ×3 | en | dosing visual proof | Bedside Prescriber Needing Instant Dosing Info | DCO | |
| 199d | ×2 | en | platform positioning | Tech-Forward Clinical Innovator | Your Clinical Intelligence Platform | DCO |
| 199d | ×2 | en | platform positioning | Tech-Forward Clinical Innovator | Your Clinical Intelligence Platform | DCO |
| 199d | ×2 | en | platform positioning | Tech-Forward Clinical Innovator | Your Clinical Intelligence Platform | DCO |
| 199d | ×2 | en | platform positioning | Tech-Forward Clinical Innovator | Your Clinical Intelligence Platform | DCO |
| 199d | ×2 | en | platform positioning | Tech-Forward Clinical Innovator | Your Clinical Intelligence Platform | DCO |
| 199d | ×2 | en | platform positioning | Tech-Forward Clinical Innovator | Your Clinical Intelligence Platform | DCO |
| 164d | ×2 | en | discount offer | Free-Tier Clinician Ready to Upgrade | Save 50% | DCO |
| 164d | ×2 | en | discount offer | Free-Tier Clinician Ready to Upgrade | Save 50% | DCO |
| 164d | ×2 | en | discount offer | Free-Tier Clinician Ready to Upgrade | Save 50% on epocrates+ | DCO |
| 164d | ×2 | en | discount offer | Free-Tier Clinician Ready to Upgrade | Save 50% | DCO |
| 162d | ×2 | en | discount offer | Free-Tier Clinician Ready to Upgrade | Save 50% on epocrates+ | DCO |
| 162d | ×2 | en | discount offer | Free-Tier Clinician Ready to Upgrade | Save 50% on epocrates+ | DCO |
| 136d | ×2 | en | discount offer | Free-Tier Clinician Ready to Upgrade | Save 50% | DCO |
Creative strategy
The dissection
epocrates' single longest-running ad (267 days) isn't a pill shot, it's a close-up of a laser tattoo removal procedure, tied to a melanoma-risk study angle. Meanwhile the volume leader is pure discount mechanics: 9 of 31 winners just say 'Save 50%' over product/app footage, no humans, no clinical drama.
Save 50%, No Faces, No Video
Discount offer is the volume leader: 9 of 31 surviving ads, all dco format (81% of the 25 x-rayed creatives), zero on-camera talent, just product and app-screen footage. The opening beat is the offer itself, literal text reading 'Save 50%' holding for 136 and 164 days straight. Six of the sampled hook mechanics are tagged discount offer, the single biggest mechanic bucket in the x-ray.
The Premium Pitch, Copied 9 Times
The exact line 'Go beyond the basics with epocrates+. Premium, evidence based clinical guidance to support confident care decisions' runs unchanged across 9 ads, while the broader platform positioning angle backs 8 winners and the Tech-Forward Clinical Innovator persona (8 ads). Same dco, no-people, app-footage build as the discount ads, just swapping the hook from a price cut to a value statement.
Instant Access Promise, 91 Paywall Complaints
Ads sell 'instant access to trusted clinical tools' (6 ads) and 50% off premium, but pricing/paywall shift is the loudest voice theme in 500 reviews (91 mentions), with reviewers calling the $15-25/month (about $180/year) jump 'sudden and excessive' after years free. App freezing/crashing adds 70 more mentions, undercutting the 'instant access' promise the copy makes.
267 Days on a Tattoo Removal Clip
The single longest-running creative in the set (267 days) isn't a pill or dosing screen, it's a close-up of a laser tattoo removal procedure, tied to a 2-ad melanoma study angle. Alongside it, 3 ads dramatize a botulinum self-injection hospitalization story and 2 more track a 13-year alcohol-intake study, feeding the Lifestyle-Risk Counseling Clinician (6 ads) and Vaccine and Prevention-Focused Clinician (3 ads) personas.
GLP-1 Persona: Just 2 Ads Deep
GLP-1 and Weight-Loss Drug Manager sits at just 2 ads, the smallest persona bucket, versus 9 for Free-Tier Clinician Ready to Upgrade and 8 for Tech-Forward Clinical Innovator. Dosing visual proof also stays thin at 3 ads, all English-only across 31 winners, zero non-English tests logged despite 75 total active ads in the library.
What we'd test next
- A dco image ad using the proven 'Save 50%' discount-offer hook over product/app footage, re-angled toward the GLP-1 and Weight-Loss Drug Manager persona (currently just 2 ads) instead of the generic clinician upgrade pitch.
- A dco ad pairing the discount-offer mechanic with a dosing-visual-proof angle (vial and syringe close-up, the 209-day and 111-day hooks) aimed at the Bedside Prescriber Needing Instant Dosing Info persona, still under-tested at 3 ads.
- An image ad introducing a social-proof rating mechanic (4.44-star badge over app screenshots) as a new hook type this set hasn't run, framed as platform positioning for the Tech-Forward Clinical Innovator persona.
- A dco platform-positioning ad translated into Spanish, testing the same 'Go beyond the basics' value-proposition hook against the Free-Tier Clinician Ready to Upgrade persona, since all 31 current winners run English-only.
The HyperScale batch
New ad concepts, generated for epocrates
HyperScale agents are producing an original round of ad concepts for epocrates, built from the winning angles above, the brand's real App Store assets, and what reviewers actually say. This page updates when the batch drops.
This analysis lives in a ready-made HyperScale workspace. If you work on epocrates, it's yours: we hand it over personally, usually within a day.
Customer voice — 497 recent reviews analyzed
What reviewers actually say
Objections the ads must pre-empt
- Free version now limits drug searches to a handful per week, breaking point-of-care workflow
- Subscription pricing ($15-25/month or ~$180/year) seen as sudden and excessive after years of free use
- App crashes or freezes on launch/sync, sometimes right after updates
- Older iOS devices/iPhones lose access entirely after update requirements
- Even paying subscribers still see ads and pop-ups
Review-theme mix
Share of analyzed review mentions per theme — ＋ praise, − complaint, ~ mixed. Themes, not individual reviews.
− pricing/paywall shift
33% · 91
− usage limits & feature restrictions
15% · 41
− app freezing/crashing
25% · 70
+ long-term loyalty
2% · 6
− ios/device compatibility
8% · 23
− ads & clutter
7% · 19
− customer support failures
6% · 16
− competitor switching
4% · 10
“I've had an Epocrates account since 2007. This used to be the best app for basic drug reference.”
“Been using the app regularly for almost 20 years”
“I have been in active practice for 40 years and have used this app when it was first introduced”
“Great resource- it is my go to. It is organized clearly and concisely. Quickly tells you what you need to know. I have used it now for over 14 years.”
“The pill identifier saved three lives over a 10 year period”
“I saved my friend's life 3 times when I found out medications contraindicated with other medications”
“I have been using Epocrates for over 20 years. It is the by far the most useful application for me that I have. I use it daily for Pediatric dosings and indications.”
“Great for finding drug interactions when the EMR doesn't!”
“This is a wonderful product, easy to use, versatile, and consistently accurate”
“Most free interaction checks only do 2 at a time. Wife is post breast cancer and has a lot of strong meds she now has to take. The free version of this app was perfect.”
“I am only able to look up 1 or 2 drugs A WEEK”
“I only looked up a few medications (maybe like 4) and get the pop up that I "reached my free amount of look ups for the week." For the week? It's literally the first day of the week.”
“"You've reached your free views for this week."”
“Went to use the medication search feature which I use multiple times daily.. told I reached my limit”
“imagine my surprise when I go to calculate a dose for a pediatric patient and get a notification I have exceeded my free views”
“As a physician, I use this app daily to check dosing before prescribing”
“LIMITING PHYSICIAN ACCESS TO VITAL DRUG INFO ACTIVELY HARMS PATIENTS”
“Despite paying $180 for a yearly membership, every time I open this app I'm forced to watch a drug commercial first”
“This is the most expensive app on my phone, and I still have to deal with adds!”
“Been using this app for years, was absolutely great. All of a sudden it won't open or more precisely crashes immediately upon launching it.”
“I use this app every day in my clinic to double-check doses and other reasons. Since updating today, the app consistently crashes as soon as it loads.”
“completely frozen after sept 2020 update”
“Crashes at 22%, no longer functional. This is the second time this has happened in the past 3 months.”
“Since the latest update last week, epocrates is inaccessible for iOS versions older that 16, that includes iPhones 7, 7 plus etc which can't download higher OS.”
“I use(d) Epocrates many times per day until the latest update. I can no longer use it unless I buy a new iPhone that supports iOS 13.”
“For the umpteenth time, delete app, reinstall, log in, still the same problem. Reached out through email few times already. No resolution. Frustrated.”
“App has been malfunctioning for 2 days. Contacted customer support, no response”
“Canceling and going with Up to Date”
The market around it
Brands competing for the same feed
Keep exploring the radar
More Meta ads teardowns
Also winning with the discount offer angle
The biggest ad sets on the radar
7,815 active ads · Education
3,060 active ads · Music
2,451 active ads · Health & Fitness
2,435 active ads · Productivity
2,058 active ads · Photo & Video
1,891 active ads · Health & Fitness
1,712 active ads · Photo & Video
Quick answers
FAQ
How many ads is epocrates running on Meta, and how many are actually winning?
Epocrates has 75 active ads in Meta's library right now, 31 of which have survived 30+ days to qualify as winners. The longest-running single creative has held for 267 days.
Which languages and angles dominate epocrates' Meta ads?
All 31 winning ads run in English. Discount offer leads with 9 ads, platform positioning follows with 8, then lifestyle risk visual (4), dosing visual proof (3), and clinical topic demo and self-injection demo tied at 2 each.
What creative pattern is actually working for epocrates?
The dco format covers 81% of x-rayed creatives with no on-camera talent, just product and app footage. The 'Save 50%' discount hook and the repeated 'Go beyond the basics with epocrates+' line (9 ads verbatim) are the two proven backbones.
What do epocrates reviewers say versus what the ads promise?
Across 500 reviews (4.44★ lifetime), pricing/paywall shift is the top complaint (91 mentions), followed by app freezing/crashing (70) and usage limits (41). Reviewers call the $15-25/month jump 'sudden and excessive' after years of free access.